Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mandy L Ballinger

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Journal of Genetic Counseling|July 4, 2021
Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing studyPhyllis Butow, Grace Davies, Christine E Napier, et al.
JAMA Network Open|May 15, 2020
Assessment of the Value of Tumor Variation Profiling Perceived by Patients With CancerPhyllis Butow, Grace Davies, Christine E Napier, et al.
Psycho-Oncology|July 9, 2021
Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profilingPhyllis Butow, Fabiola Müller, Christine E Napier, et al.
Patient Education and Counseling|February 14, 2022
Psychological impact of comprehensive tumor genomic profiling results for advanced cancer patientsPhyllis N Butow, Megan C Best, Grace Davies, et al.
Genetics in Medicine Open|December 13, 2024
Increased frequency of <i>CHEK2</i> germline pathogenic variants among individuals with dermatofibrosarcoma protuberansMichael R Sargen, Jung Kim, Jeremy S Haley, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|May 23, 2022
Psychological outcomes in advanced cancer patients after receiving genomic tumor profiling resultsSabina Vatter, Timothy E Schlub, Christine E Napier, et al.
Clinical Genetics|November 2, 2019
Who should access germline genome sequencing? A mixed methods study of patient viewsMegan C Best, Phyllis Butow, Chris Jacobs, et al.
American Journal of Medical Genetics. Part A|November 10, 2021
Psychological predictors of advanced cancer patients' preferences for return of results from comprehensive tumor genomic profilingBettina Meiser, Phyllis Butow, Grace Davies, et al.
Familial Cancer|January 27, 2017
Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?Kate A McBride, Mandy L Ballinger, Timothy E Schlub, et al.
Patient Education and Counseling|July 12, 2021
Cancer patient knowledge about and behavioral intentions after germline genome sequencingChristine E Napier, Grace Davies, Phyllis N Butow, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Journal of Genetic Counseling|July 4, 2021
Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing studyPhyllis Butow, Grace Davies, Christine E Napier, et al.
JAMA Network Open|May 15, 2020
Assessment of the Value of Tumor Variation Profiling Perceived by Patients With CancerPhyllis Butow, Grace Davies, Christine E Napier, et al.
Psycho-Oncology|July 9, 2021
Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profilingPhyllis Butow, Fabiola Müller, Christine E Napier, et al.
Patient Education and Counseling|February 14, 2022
Psychological impact of comprehensive tumor genomic profiling results for advanced cancer patientsPhyllis N Butow, Megan C Best, Grace Davies, et al.
Genetics in Medicine Open|December 13, 2024
Increased frequency of <i>CHEK2</i> germline pathogenic variants among individuals with dermatofibrosarcoma protuberansMichael R Sargen, Jung Kim, Jeremy S Haley, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|May 23, 2022
Psychological outcomes in advanced cancer patients after receiving genomic tumor profiling resultsSabina Vatter, Timothy E Schlub, Christine E Napier, et al.
Clinical Genetics|November 2, 2019
Who should access germline genome sequencing? A mixed methods study of patient viewsMegan C Best, Phyllis Butow, Chris Jacobs, et al.
American Journal of Medical Genetics. Part A|November 10, 2021
Psychological predictors of advanced cancer patients' preferences for return of results from comprehensive tumor genomic profilingBettina Meiser, Phyllis Butow, Grace Davies, et al.
Familial Cancer|January 27, 2017
Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?Kate A McBride, Mandy L Ballinger, Timothy E Schlub, et al.
Patient Education and Counseling|July 12, 2021
Cancer patient knowledge about and behavioral intentions after germline genome sequencingChristine E Napier, Grace Davies, Phyllis N Butow, et al.
Pageof 9